Literature DB >> 15546223

Written emotional disclosure buffers the effects of social constraints on distress among cancer patients.

Sandra G Zakowski1, Alona Ramati, Carla Morton, Peter Johnson, Robert Flanigan.   

Abstract

The aims of the present study were to examine whether written emotional disclosure would reduce distress among cancer patients and whether it would buffer the effects of high levels of social constraint (negative social responses to patients' expressions of emotion regarding their cancer) on distress. Cancer patients (N=104) were randomly assigned to write about their emotions regarding their cancer 20 min a day for 3 days or to write about a nonemotional topic. They completed questionnaires at baseline and 6 months postintervention. Results showed that written disclosure buffered the effects of social constraints on stress at the 6-month follow-up and that avoidance partly mediated these effects. The present data reinforce the notion that interventions should be tailored to patients' needs. ((c) 2004 APA, all rights reserved).

Entities:  

Mesh:

Year:  2004        PMID: 15546223     DOI: 10.1037/0278-6133.23.6.555

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  37 in total

Review 1.  Who benefits from psychosocial interventions in oncology? A systematic review of psychological moderators of treatment outcome.

Authors:  Rie Tamagawa; Sheila Garland; Marcus Vaska; Linda E Carlson
Journal:  J Behav Med       Date:  2012-01-22

2.  Self-report and linguistic indicators of emotional expression in narratives as predictors of adjustment to cancer.

Authors:  Jason E Owen; Janine Giese-Davis; Matt Cordova; Carol Kronenwetter; Mitch Golant; David Spiegel
Journal:  J Behav Med       Date:  2006-07-15

3.  Psychological adjustment following diagnosis and treatment of cancer: an examination of the moderating role of positive and negative emotional expressivity.

Authors:  Phillip J Quartana; Kimberly K Laubmeier; Sandra G Zakowski
Journal:  J Behav Med       Date:  2006-08-08

4.  Randomised trial of expressive writing for distressed metastatic breast cancer patients.

Authors:  Catherine E Mosher; Katherine N Duhamel; Joanne Lam; Maura Dickler; Yuelin Li; Mary Jane Massie; Larry Norton
Journal:  Psychol Health       Date:  2011-07-08

5.  Communication of emotion in home hospice cancer care: Implications for spouse caregiver depression into bereavement.

Authors:  Maija Reblin; Brian R W Baucom; Margaret F Clayton; Rebecca Utz; Michael Caserta; Dale Lund; Kathi Mooney; Lee Ellington
Journal:  Psychooncology       Date:  2019-04-05       Impact factor: 3.894

6.  Ambivalence over emotional expression and perceived social constraints as moderators of relaxation training and emotional awareness and expression training for irritable bowel syndrome.

Authors:  Hannah J Holmes; Elyse R Thakur; Jennifer N Carty; Maisa S Ziadni; Heather K Doherty; Nancy A Lockhart; Howard Schubiner; Mark A Lumley
Journal:  Gen Hosp Psychiatry       Date:  2018-05-03       Impact factor: 3.238

Review 7.  Emotional disclosure interventions for chronic pain: from the laboratory to the clinic.

Authors:  Mark A Lumley; Elyse R Sklar; Jennifer N Carty
Journal:  Transl Behav Med       Date:  2012-03       Impact factor: 3.046

8.  Living with metastatic breast cancer: a qualitative analysis of physical, psychological, and social sequelae.

Authors:  Catherine E Mosher; Courtney Johnson; Maura Dickler; Larry Norton; Mary Jane Massie; Katherine DuHamel
Journal:  Breast J       Date:  2013-03-26       Impact factor: 2.431

9.  Relaxation training and written emotional disclosure for tension or migraine headaches: a randomized, controlled trial.

Authors:  Pamela J D'Souza; Mark A Lumley; Christina A Kraft; John A Dooley
Journal:  Ann Behav Med       Date:  2008-08-12

10.  Health effects of expressive writing on stressful or traumatic experiences - a meta-analysis.

Authors:  Carolin Mogk; Sebastian Otte; Bettina Reinhold-Hurley; Birgit Kröner-Herwig
Journal:  Psychosoc Med       Date:  2006-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.